Clinical Trial: NRG GY019

NRG GY019

Status: Closed

A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

Eligible for screening study DCP 001

GY019 is Closed to Accrual, effective May 9, 2025.